Evidence map›Paper›PMID 41371654›Full record

ArticleInternal medicine (Tokyo, Japan)2026

Challenges and Strategies in Cryoablation of Para-Hisian Ventricular Arrhythmia: Insights from Two Intractable Cases.

Tadashi Hoshiyama, Kohei Matsunaga, Shinsuke Hanatani, Hitoshi Sumi, Shozo Kaneko, Hisanori Kanazawa, Yuichiro Tsuruta, Kenichi Tsujita

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tadashi HoshiyamaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan.
Kohei MatsunagaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan.
Shinsuke HanataniDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan.
Hitoshi SumiDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan.
Shozo KanekoDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan.
Hisanori KanazawaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan.
Yuichiro TsurutaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan.
Kenichi TsujitaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of the Freezor Xtra catheter (Medtronic, Minneapolis, USA) is preferred for atrioventricular nodal reentrant tachycardia owing to its low atrioventricular block risk. Therefore, use of this catheter is occasionally applied to para-Hisian ventricular arrhythmia (VA). However, the tips for catheter use in intractable cases remain challenging. This report consists of two cases of drug-resistant VAs originating from para-His. Case 1 involved a 76-year-old man who was treated VA using the reverse bending catheter technique. Case 2 involved 59-year-old man with VA who was treated at the earliest left ventricular activation site using a transseptal approach. These cases highlight the practical strategies for challenging para-His VA cases.

Indexed as

Bundle of HisCryosurgeryTachycardia, Atrioventricular Nodal ReentryTachycardia, VentricularAgedCatheter AblationElectrocardiographyHumansMaleMiddle Agedcryoablationintractablepara-His originventricular arrhythmia

Identifiers

PMID41371654
PMCPMC13447688

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.